Invited Panel Session
Global Impact of the ICH E9(R1) Addendum - 5-Year Anniversary for the Trial Estimand Framework
Elena PolverejanOrganizerFrank BretzChair
Biopharmaceutical Section
3 Panelists
The US FDA
Health Canada
Pharmaceuticals & Medical Devices Agency